Sunobinop tosylate is under clinical development by Imbrium Therapeutics and currently in Phase II for Insomnia. According to GlobalData, Phase II drugs for Insomnia have a 44% phase transition ...

Department of Chemistry, Oklahoma State University, Stillwater, Oklahoma 74078, United States ...

University of Göttingen, Institute of Inorganic Chemistry, Tammannstrasse 4, D-37077 Göttingen, Germany ...